In biotechnology, speed matters.
Emerging technology has opened a new world of possibilities for treating — and potentially curing — diseases. Scientists are developing cell and gene therapies designed to help patients with cancer, heart disease, liver disease, Parkinson’s disease, Alzheimer’s and many other conditions. The faster they can get these therapies from the laboratory through clinical trials and into production, the sooner people will be able to benefit.
But the process of getting discoveries to market is complex. Working with biologics, which are extracted from living cells, is different than working with chemically derived small molecules. It requires new approaches to research, development and manufacturing that make commercialization challenging.
Across Montgomery County in Maryland, where growth in the life sciences sector is booming, organizations are creating the conditions needed to accelerate speed to market.
Read the full article at: www.bizjournals.com
